tesamorelin
Showing 1 - 8 of 8
COPD (COPD) Trial (Tesamorelin, Placebo)
Terminated
- Chronic Obstructive Pulmonary Disease (COPD)
- Tesamorelin
- Placebo
- (no location specified)
Mar 9, 2022
HIV Lipodystrophy Syndrome, Growth Hormone Deficiency, Body Composition Trial in New York (Tesamorelin)
Recruiting
- HIV Lipodystrophy Syndrome
- +2 more
- Tesamorelin
-
New York, New YorkNeuroendocrine Unit and Pituitary Center, Columbia University
Jul 12, 2021
Lipodystrophy, HIV Trial in Worldwide (Tesamorelin, Placebo for Tesamorelin)
Completed
- Lipodystrophy
- HIV Infections
- Tesamorelin
- Placebo for Tesamorelin
-
Birmingham, Alabama
- +46 more
Sep 16, 2022
Human Immunodeficiency Virus (HIV), Nonalcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis (NASH) Trial in
Completed
- Human Immunodeficiency Virus (HIV)
- +2 more
- tesamorelin
- Placebo
-
Bethesda, Maryland
- +1 more
Jan 13, 2020
Sleep Disorder, Traumatic Brain Injury Trial (Tesamorelin, Placebo)
Withdrawn
- Sleep Disorder
- Traumatic Brain Injury
- Tesamorelin
- Placebo
- (no location specified)
Nov 16, 2019
HIV, HIV Lipodystrophy Trial in Boston (tesamorelin, )
Completed
- HIV
- HIV Lipodystrophy
- tesamorelin
- placebo
-
Boston, MassachusettsMassachusetts General Hospital
Sep 28, 2017
Abdominal Obesity Trial in Boston (Tesamorelin, Placebo)
Withdrawn
- Abdominal Obesity
- Tesamorelin
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Jan 23, 2014
HIV Trial in Montreal (Tesamorelin)
Completed
- HIV
- Tesamorelin
-
Montreal, Quebec, CanadaAnapharm Montreal
Dec 10, 2013